International Neuromodulation Society

“The treasurer, bookkeeper and executive director review the form 990 independently and provide their comments, if any, to the accountant preparing the form.”

“Ins has a conflicts policy in place, but no conflicts have arisen as of yet.”

“The annual process for determining compensation is as follows: the ins executive board shall annually evaluate the executive director, public education manager, and editorial assistant on his/her performance, and ask for his/her input on matters of performance and compensation. The executive board will obtain research and information to inform their decision on the compensation (salary and benefits) based on a review of comparability data”

“The governing documents (bylaws) and coi policy are posted on the website. The financial statements are available upon request.”

“Complete mission statement of international neuromodulation society the mission of the ins is to promote and disseminate the science, education, practice and accessibility of all aspects of neuromodulation. This multidisciplinary society believes that all scientists, doctors, bioengineers, professions allied to medicine and industry partners who have a specialist interest in neuromodulation can work with this society to share science and encourage best practice for the good of humanity. The vision of the ins is to harness all scientific, clinical and engineering endeavor throughout the world and to brand neuromodulation to encompass all neurological technologies that through electrical or chemical means improve the function of the impaired individual. The goals of the ins are: to create a forum for clinicians, basic scientists and bioengineers involved with neuromodulation through a combination of scientific meetings, journal and interactive website; to create a family of affiliated neuromodulation national chapters to encourage growth and influence at national level; to encourage research and development into the conditions treated and the devices and techniques used; to encourage open dialogue with industry partners and health care authorities to improve understanding of these therapies, the needs of patients, service requirements and fair remuneration; to expand the worldwide access to neuromodulation by raising awareness of the both its clinical efficacy and cost effectiveness. Program service accomplishment statement1, continued: for clinicians, engineers, scientists and members of the biotechnology industry alike, neuromodulation provides timely and rigorously peer reviewed articles on the technology, science and clinical application of devices that interface with the nervous system to treat disease and improve function. Neuromodulation covers an ever expanding field including pain, headache,movement disorders, spasticity, paralysis, psychiatric disorders, cognitive disorders, epilepsy, sensory deprivation, gastric dysfunction, obesity, incontinence and systemic disease. The journal represents the practice of a growing, diverse multidisciplinary field responsible for the development and application of devices and techniques to benefit patients by normalizing function and reducing suffering. In depth reviews, original articles, national and international meeting abstracts, special focus editions and web based educational offerings help the reader to expand their knowledge and understanding of the interface between electrical stimulation, chemical neuromodulation, the nervous system and the patient. Our updates on past and future news of events and activities of the ins and its membership keep the reader abreast of issues related to professional education and development. Program service accomplishment statement3, continued: therefore, this conference will appeal to and educate the diverse population of anticipated attendees (neurosurgeons, neurologists, anesthesiologists, physiatrists, cardiologists, urologists, basic scientists, biomedical engineers, and industry representatives) from around the globe and provide a unique forum for discourse. Amongst some specialists outside of the neuromodulation community, there is a general lack of awareness and/or skepticism of the technology and therapies available to their patients and the ins strives to educate the uninitiated and dispel any misinformation about the existence and effectiveness of neuromodulation to treat movement disorders, psychiatric disorders, chronic pain, angina, peripheral vascular disease, bladder dysfunction and gastrointestinal / colorectal dysfunction, etc. It is therefore incumbent upon our society to bridge the gaps between specialties and continents, to educate and enable exchange of this scientific information and, ultimately, to provide the tools needed to improve patient care.”